Loading...
Last update:  November 5, 2019
08:02 +1GMT

Allergenic Molecule  Tri a 19Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE1400.71020130111, Ott H
1.3 - Rhinitis, Diagnosed2013BrazilIgE1010.00020130912, Lacerda Araujo LM
6.5 - Occupational Exposure2013ItalyIgE510.00020130520, Olivieri M
5.2.4 - Source Exposed, Adults (Symptoms, IgE)2013AustriaIgE3751.35020131216, Baar A
1.6 - Anaphylaxis, Diagnosed2013JapanIgE3650.00020130424, Kohno K
1.5 - Atopic Dermatitis, Diagnosed2013AustriaIgE150.00020131216, Baar A
4.1.5 - Heterologous Source Sensitized (IgE)2013AustriaIgE1414.28020131216, Baar A
6.2 - General Population (Adults)2012SwedenIgE3710.00020120528, Patelis A
5.3.1 - Source Exposed (Symptoms, IgE)2012JapanIgE17372.25020120103, Ebisawa M
3.2.1 - Source Sensitized (IgE)2012JapanIgE13824.64020120103, Ebisawa M
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE991.01020110223, De Knop KJ
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE960.00020120528, Patelis A
5.2.5 - Source Exposed, Children (Symptoms, IgE)2012FranceIgE8245.12020121030, Mameri H
5.3.1 - Source Exposed (Symptoms, IgE)2012JapanIgE5479.60020121024, Chinuki Y
5.3.1 - Source Exposed (Symptoms, IgE)2012JapanIgE306.60020121024, Chinuki Y
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012Austria / ItalyIgE296.90020120123, Pahr S
6.5 - Occupational Exposure2012FranceIgE2913.79020121030, Mameri H
10.1 - Normal Control2012BelgiumIgE279.00020110223, De Knop KJ
5.2.4 - Source Exposed, Adults (Symptoms, IgE)2012FranceIgE2157.14020121030, Mameri H
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012GermanyIgE1782.35020120917, Hofmann SC
10.1 - Normal Control2012FranceIgE128.33020121030, Mameri H
1.9 - Pollen Allergy2012FranceIgE1010.00020121030, Mameri H
6.5 - Occupational Exposure2011GermanyIgE402.50020110511, Sander I
5.3.1 - Source Exposed (Symptoms, IgE)2011Korea, Republic ofIgE17100.00020111011, Park HJ
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2011GermanyIgE100.00020110511, Sander I
5.3.1 - Source Exposed (Symptoms, IgE)2010JapanIgE23100.00020101124, Fukutomi Y
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE370.00020090826, Ebo DG
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2009FranceIgE2466.66020081126, Jacquenet S
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE220.00020091121, Ebo DG
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE200.00020091121, Ebo DG
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE200.00020091005, Ott H
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2008JapanIgE5080.00020080104, Matsuo H
Developed by
Panservice